Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 13.3B | 14.6B | 15.8B | 12.8B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 1.4B | 2.3B | 3.3B | 976M |
| Tax provision | 223M | 144M | 177M | 143M |
| Net income | 1.2B | 2.1B | 3.1B | 833M |
| Basic EPS | 74 | — | 193 | 51 |
| Diluted EPS | 74 | — | 193 | 51 |
| Basic average shares | 15.7M | — | 15.8M | 15.6M |
| Diluted average shares | 15.7M | — | 15.8M | 15.6M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 1.3B | 2.1B | 3.3B | 963M |
| Minority interests | -45M | -25M | -32M | -35M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |